Ovulation inhibition with different doses of levonorgestrel and other progestogens: clinical and experimental investigations.
D000328:Adult; D000818:Animals; D002369:Castration; D002499:Centrifugation, Density Gradient; D003534:Cyproterone / Q000494:pharmacology; D003600:Cytosol / Q000032:analysis; D004305:Dose-Response Relationship, Drug; D005260:Female; D005640:Follicle Stimulating Hormone / Q000378:metabolism; D007987:Gonadotropin-Releasing Hormone; D006801:Humans; D007986:Luteinizing Hormone / Q000378:metabolism; D008954:Models, Biological; D009644:Norgestrel / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology; D010060:Ovulation / Q000187:drug effects*; D010903:Pituitary Gland, Anterior / Q000378:metabolism; D011372:Progestins / Q000494:pharmacology*; D011485:Protein Binding; D051381:Rats; D011980:Receptors, Progesterone / Q000032:analysis; D013237:Stereoisomerism
D011372:Progestins; D011980:Receptors, Progesterone; D007987:Gonadotropin-Releasing Hormone; D009644:Norgestrel; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D003534:Cyproterone